Body Pharm Client Login

Tesamorelin 32

5.0 · 22 verified reviews

Tesamorelin is a synthetic GHRH analogue, the full 44-amino-acid GHRH sequence with a stabilising N-terminal modification, and among the most extensively characterised growth-hormone-releasing peptides in clinical research. 32mg, with published HPLC purity results. Stored refrigerated at 2–8°C.

98.10%Tesamorelin purity, report #260228
HPLCTested every batch
Full lab results and certificate of analysis →
  • Certificates of analysis published for every batch
  • cGMP aseptic fill, ISO 5 laboratory
  • Shipped cold-chain in insulated packaging

Sold for laboratory and research purposes only. Not for human consumption. 18+.

Free guideTesamorelin: the research explained

What clients say

★★★★★

Great Service! i'll sure be sure to reorder

Suzi · Verified buyer · Jul 2026
★★★★★

Very informative and helpful pre purchase and post. After care is incredible. Great job, keep it up

Omaad N. · Verified buyer · Jun 2026

About Tesamorelin 32

Tesamorelin is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), consisting of the full 44-amino-acid GHRH sequence with a trans-3-hexenoic acid group added to the N-terminus to improve stability and half-life. It is the only FDA-approved GHRH analogue, authorised under the trade name Egrifta for reduction of excess visceral adipose tissue (VAT) in HIV-infected adults with lipodystrophy - a status that makes it one of the most rigorously characterised GHRH analogues in clinical research.

Research beyond lipodystrophy has explored tesamorelin in the context of cognitive aging. A notable clinical study at Vanderbilt University (2019) examined tesamorelin's effects on memory and executive function in older adults with mild cognitive impairment, finding significant improvements in verbal memory in the treated group - suggesting possible connections between GH axis activity, IGF-1 signalling, and hippocampal function that warrant further investigation.

Tesamorelin has also been investigated in non-alcoholic fatty liver disease (NAFLD) models and in general age-related GH axis decline (somatopause) research, given the well-documented decline in GH secretory amplitude with aging.

Requires refrigeration at 2-8°C. For research purposes only; not approved for therapeutic use in the UAE.

Specification

Total Content
32mg
Purity
See batch CoA
Storage
2-8°C Refrigerated
Active Ingredient
Tesamorelin
Compound Name
Tesamorelin
CAS Number
218949-48-5
Molecular Weight
~5135.9 g/mol (free base; acetate salt ~5579 g/mol)
Verification
HPLC (in-house)

Research areas

Full lab results and certificate of analysis →

Research background

Tesamorelin is a GHRH(1-44) analogue with an N-terminal trans-3-hexenoic acid group that resists DPP-4 degradation and extends stability. In vitro it binds the GHRH receptor on pituitary somatotrophs and is studied as a secretagogue that drives endogenous, pulsatile GH release rather than supplying growth hormone directly.

Downstream research examines IGF-1 signalling and lipid handling, with particular interest in visceral adipose tissue, and it serves as a well-characterised reference GHRH analogue in growth-hormone-axis and metabolic studies. Supplied for in vitro and laboratory research only.

Read the full guide: Tesamorelin: the research explained →

More research compounds

Free research guides

Open to everyone: the research behind each compound, our lab results and how we work.

Why BodyPharm

The standard other suppliers don’t meet

COA testing
Publicly available in-house and third-party certificates with every batch, guaranteed.
ISO 5 facilities
Fully cGMP automated aseptic production line within ISO 5 certified laboratories.
Cold chain
From our labs to yours. Full cold-chain delivery to ensure stability and quality.

Frequently Asked Questions